Literature DB >> 25874720

Effects of low-level carotid baroreflex stimulation on atrial electrophysiology.

Mingyan Dai1, Mingwei Bao, Jiafen Liao, Lilei Yu, Yanhong Tang, He Huang, Xi Wang, Congxin Huang.   

Abstract

PURPOSE: This study aimed to investigate the effects of low-level carotid baroreflex stimulation (LL-CBS) on atrial electrophysiology.
METHODS: In protocol 1 (LL-CBS on physiological state), anesthetized rabbits were subjected to LL-CBS (n = 10) or surgical exposure (n = 6) for 1 h. In protocol 2 (LL-CBS on acute rapid atrial pacing), anesthetized rabbits underwent 3 h of rapid atrial pacing (RAP) with concomitant LL-CBS in the third hour (n = 7) or 3h-RAP without LL-CBS (n = 6). Carotid baroreceptor surrounded by electrodes allowed LL-CBS at 20 % below the voltage required to reduce systolic blood pressure or heart rate. Effective refractory period (ERP) and monophasic action potential duration (MAPD) were determined, and power spectral of heart rate variability (HRV) was analyzed at baseline as well as after interventions in all groups, respectively.
RESULTS: In protocol 1, LL-CBS significantly prolonged the ERPs, MAPD90, and MAPD50 and increased high-frequency (HF) HRV component but it decreased low-frequency (LF) HRV component and LF/HF ratio. In protocol 2, 3h-RAP significantly shortened ERPs, MAPD90, and MAPD50 and decreased HF but it increased LF and LF/HF ratio. However, LL-CBS reversed the variations caused by RAP.
CONCLUSIONS: LL-CBS prolongs ERPs and MAPD of the left atrium and attenuates RAP-induced atrial electrical remodeling including the shortening of ERPs and MAPD, probably by modulating the autonomic nervous system.

Entities:  

Mesh:

Year:  2015        PMID: 25874720     DOI: 10.1007/s10840-015-9976-5

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  51 in total

1.  Interactions between atrial electrical remodeling and autonomic remodeling: how to break the vicious cycle.

Authors:  Lilei Yu; Benjamin J Scherlag; Yong Sha; Shaolong Li; Tushar Sharma; Hiroshi Nakagawa; Warren M Jackman; Ralph Lazzara; Hong Jiang; Sunny S Po
Journal:  Heart Rhythm       Date:  2011-12-31       Impact factor: 6.343

2.  Effect of bepridil in atrial fibrillation inducibility facilitated by vagal nerve stimulation. - Prevention of vagal nerve activation-induced shortening of the atrial action potential duration -.

Authors:  Kenichi Iijima; Masaomi Chinushi; Daisuke Izumi; Shizue Ahara; Hiroshi Furushima; Satoru Komura; Yukio Hosaka; Akiko Sanada; Akinori Sato; Yoshifusa Aizawa
Journal:  Circ J       Date:  2010-04-03       Impact factor: 2.993

Review 3.  Low-frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may be a measure of modulation of cardiac autonomic outflows by baroreflexes.

Authors:  David S Goldstein; Oladi Bentho; Mee-Yeong Park; Yehonatan Sharabi
Journal:  Exp Physiol       Date:  2011-09-02       Impact factor: 2.969

4.  Rheos Baroreflex Hypertension Therapy System to treat resistant hypertension.

Authors:  Ingrid J M Scheffers; Abraham A Kroon; Jan H M Tordoir; Peter W de Leeuw
Journal:  Expert Rev Med Devices       Date:  2008-01       Impact factor: 3.166

5.  Power spectral analysis of heart rate variability and autonomic nervous system activity measured directly in healthy dogs and dogs with tachycardia-induced heart failure.

Authors:  Gianfranco Piccirillo; Masahiro Ogawa; Juan Song; Voon J Chong; Boyoung Joung; Seongwook Han; Damiano Magrì; Lan S Chen; Shien-Fong Lin; Peng-Sheng Chen
Journal:  Heart Rhythm       Date:  2009-01-16       Impact factor: 6.343

Review 6.  Baroreflex activation: from mechanisms to therapy for cardiovascular disease.

Authors:  Radu Iliescu; Ionut Tudorancea; Thomas E Lohmeier
Journal:  Curr Hypertens Rep       Date:  2014-08       Impact factor: 5.369

7.  Prolonged activation of the baroreflex produces sustained hypotension.

Authors:  Thomas E Lohmeier; Eric D Irwin; Martin A Rossing; David J Serdar; Robert S Kieval
Journal:  Hypertension       Date:  2004-01-05       Impact factor: 10.190

8.  Effect of renal sympathetic denervation on the inducibility of atrial fibrillation during rapid atrial pacing.

Authors:  Qingyan Zhao; Shengbo Yu; Minghui Zou; Zixuan Dai; Xule Wang; Jinping Xiao; Congxin Huang
Journal:  J Interv Card Electrophysiol       Date:  2012-08-07       Impact factor: 1.900

9.  Effects of electrical stimulation of carotid baroreflex and renal denervation on atrial electrophysiology.

Authors:  Dominik Linz; Felix Mahfoud; Ulrich Schotten; Christian Ukena; Hans-Ruprecht Neuberger; Klaus Wirth; Michael Böhm
Journal:  J Cardiovasc Electrophysiol       Date:  2013-05-02

10.  Low-level carotid baroreceptor stimulation suppresses ventricular arrhythmias during acute ischemia.

Authors:  Kai Liao; Lilei Yu; Kang Yang; Gaowa Saren; Songyun Wang; Bing Huang; Hong Jiang
Journal:  PLoS One       Date:  2014-10-06       Impact factor: 3.240

View more
  4 in total

Review 1.  New approaches for treating atrial fibrillation: Focus on autonomic modulation.

Authors:  Daniel Sohinki; Stavros Stavrakis
Journal:  Trends Cardiovasc Med       Date:  2019-10-31       Impact factor: 6.677

2.  Carotid baroreceptor stimulation in obese rats affects white and brown adipose tissues differently in metabolic protection.

Authors:  Quan Cao; Junxia Zhang; Qiao Yu; Jing Wang; Mingyan Dai; Yijie Zhang; Qiang Luo; Mingwei Bao
Journal:  J Lipid Res       Date:  2019-05-24       Impact factor: 5.922

3.  Cardioprotective effects of low-level carotid baroreceptor stimulation against myocardial ischemia-reperfusion injury in canine model.

Authors:  Xia Sheng; Mingxian Chen; Bing Huang; Jia Liu; Liping Zhou; Mingwei Bao; Shuyan Li
Journal:  J Interv Card Electrophysiol       Date:  2016-01-06       Impact factor: 1.900

Review 4.  Autonomic Modulation of Cardiac Arrhythmias: Methods to Assess Treatment and Outcomes.

Authors:  Stavros Stavrakis; Kanchan Kulkarni; Jagmeet P Singh; Demosthenes G Katritsis; Antonis A Armoundas
Journal:  JACC Clin Electrophysiol       Date:  2020-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.